Asako Yamayoshi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Multiple Myeloma

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Chisato Terada, Kaho Oh, Ryutaro Tsubaki, Bun Chan, Nozomi Aibara, Kaname Ohyama, Masa-Aki Shibata, Takehiko Wada, Mariko Harada-Shiba, Asako Yamayoshi, Tsuyoshi Yamamoto
Publisher Correction: Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry. Nature communications 15 (1) (2024)
Chisato Terada, Kaho Oh, Ryutaro Tsubaki, Bun Chan, Nozomi Aibara, Kaname Ohyama, Masa-Aki Shibata, Takehiko Wada, Mariko Harada-Shiba, Asako Yamayoshi, Tsuyoshi Yamamoto
Publisher Correction: Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry. Nature communications 15 (1) (2024)
Yu Mikame, Asako Yamayoshi
Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids. Pharmaceutics 15 (10) (2023)
Chisato Terada, Kaho Oh, Ryutaro Tsubaki, Bun Chan, Nozomi Aibara, Kaname Ohyama, Masa-Aki Shibata, Takehiko Wada, Mariko Harada-Shiba, Asako Yamayoshi, Tsuyoshi Yamamoto
Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry. Nature communications 14 (1) (2023)
Chisato Terada, Seiya Kawamoto, Asako Yamayoshi, Tsuyoshi Yamamoto
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules. Pharmaceutics 14 (12) (2022)
Chisato Terada, Seiya Kawamoto, Asako Yamayoshi, Tsuyoshi Yamamoto
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules. Pharmaceutics 14 (12) (2022)
Chisato Terada, Seiya Kawamoto, Asako Yamayoshi, Tsuyoshi Yamamoto
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules. Pharmaceutics 14 (12) (2022)
Chisato Terada, Seiya Kawamoto, Asako Yamayoshi, Tsuyoshi Yamamoto
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules. Pharmaceutics 14 (12) (2022)
Atsuhiro Kojima, Juki Nakao, Naohiko Shimada, Naoki Yoshida, Yota Abe, Yu Mikame, Tsuyoshi Yamamoto, Takehiko Wada, Atsushi Maruyama, Asako Yamayoshi
Selective Photo-Crosslinking Detection of Methylated Cytosine in DNA Duplex Aided by a Cationic Comb-Type Copolymer. ACS biomaterials science & engineering 8 (5) (2022)
Emi Soma, Asako Yamayoshi, Yuki Toda, Yuji Mishima, Shigekuni Hosogi, Eishi Ashihara
Successful Incorporation of Exosome-Capturing Antibody-siRNA Complexes into Multiple Myeloma Cells and Suppression of Targeted mRNA Transcripts. Cancers 14 (3) (2022)
Tsuyoshi Yamamoto, Yahiro Mukai, Fumito Wada, Chisato Terada, Yukina Kayaba, Kaho Oh, Asako Yamayoshi, Satoshi Obika, Mariko Harada-Shiba
Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides. Pharmaceutics 13 (6) (2021)
Asako Yamayoshi, Hiroyuki Fukumoto, Rie Hayashi, Kyosuke Kishimoto, Akio Kobori, Yoshio Koyanagi, Jun A Komano, Akira Murakami
Development of 7SK snRNA Mimics That Inhibit HIV Transcription. ChemMedChem 16 (20) (2021)
Shintaro Fumoto, Tsuyoshi Yamamoto, Kazuya Okami, Yuina Maemura, Chisato Terada, Asako Yamayoshi, Koyo Nishida
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs. Pharmaceutics 13 (2) (2021)
Shota Oyama, Tsuyoshi Yamamoto, Asako Yamayoshi
Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs. Cancers 13 (15) (2021)
Asako Yamayoshi, Shota Oyama, Yusuke Kishimoto, Ryo Konishi, Tsuyoshi Yamamoto, Akio Kobori, Hiroshi Harada, Eishi Ashihara, Hiroshi Sugiyama, Akira Murakami
Development of Antibody-Oligonucleotide Complexes for Targeting Exosomal MicroRNA. Pharmaceutics 12 (6) (2020)
Asako Yamayoshi, Maiko Higuchi, Yui Sakai, Akio Kobori, Tsuyoshi Yamamoto, Takayuki Shibata, Akira Murakami
Selective cross-linking behavior of oligodeoxyribonucleotides containing 2'-O-[N-(4,5',8-trimethylpsoralen-4'-ylmethylcarbamoyl)]adenosine to mutant H-ras DNA. Nucleosides, nucleotides & nucleic acids 39 (1-3) (2019)